Marksans Pharma Limited (NSE:MARKSANS)
India · Delayed Price · Currency is INR 178.20
-6.09 (-3.30%)
Aug 14, 2025, 3:30 PM IST
Marksans Pharma Market Cap
Marksans Pharma has a market cap or net worth of 80.93 billion as of August 14, 2025. Its market cap has decreased by -11.53% in one year.
Market Cap
80.93B
Enterprise Value
77.31B
Revenue
26.52B
Ranking
n/a
PE Ratio
23.07
Stock Price
178.20
Market Cap Chart
Since December 13, 2006, Marksans Pharma's market cap has increased from 3.65B to 80.93B, an increase of 2,116.20%. That is a compound annual growth rate of 18.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 83.51B | -37.88% |
| Dec 31, 2024 | 134.43B | 84.14% |
| Dec 29, 2023 | 73.00B | 210.96% |
| Dec 30, 2022 | 23.48B | -4.66% |
| Dec 31, 2021 | 24.63B | -0.80% |
| Dec 31, 2020 | 24.82B | 263.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,892.20B |
| Divi's Laboratories | 1,582.46B |
| Cipla | 1,229.07B |
| Apollo Hospitals Enterprise | 1,040.50B |
| Mankind Pharma | 1,003.22B |
| Zydus Lifesciences | 961.61B |
| Fortis Healthcare | 703.36B |
| Alkem Laboratories | 615.64B |